The Royal Oldham Hospital is a NHS hospital in the Coldhurst area of Oldham, Greater Manchester, England. It is managed by the Northern Care Alliance NHS Foundation Trust. The hospital has its own volunteer-run radio station, Radio Cavell, which broadcasts at 1350 AM.

During the past decade, Royal Oldham Hospital conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 7 clinical trials were completed, i.e. on average, 36.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Oldham Hospital" #1 sponsor was "Allergan" with 4 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "Pennine Acute Hospitals NHS Trust" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "University Hospital Southampton NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Oldham Hospital" #1 collaborator was "Cancer Research UK" with 3 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator and "Berry Consultants" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Royal Oldham Hospital" are "Breast Cancer" (5 trials), "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Multiple Myeloma" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Royal Oldham Hospital" in a lesser frequency.

Most popular intervention types in "Royal Oldham Hospital" are "Drug" (18 trials), "Biological" (4 trials), "Other" (4 trials), "Procedure" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Relamorelin" (3 trials), "bococizumab (PF-04950615)" (2 trials), "pegfilgrastim" (2 trials) and "0.9% Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Oldham Hospital" are 27 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Oldham Hospital". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Royal Oldham Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Oldham Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".